What You Should Know:
– Carna Health, a digital health company focused on kidney care, has announced a strategic agreement with Siemens Healthineers. The collaboration aims to accelerate the adoption of Carna’s AI-enabled chronic kidney…
Continue Reading
Oxford University spin-out OrganOx has been acquired by Terumo Corporation in a $1.5bn (£1.2bn) deal, representing one of the largest exits of a UK MedTech company.
The firm, founded by Constantin Coussios and Peter Friend,…
What You Should Know:
– New data from Nomi Health reveals a counterintuitive trend dubbed the “MSK Paradox”: white-collar employees report significantly higher rates of musculoskeletal (MSK) disorders than their blue-collar counterparts.
– A national analysis…
Continue Reading
Jordan Sollof
Digital Health Unplugged covers all things health technology and NHS IT. Hosted by Digital Health’s news reporter Jordan Sollof, the podcast delves into key issues and news stories in the sector. It also…
Continue Reading
Opioids are frequently overprescribed after surgery. We applied a tabular foundation model to predict the risk of post-discharge opioid consumption. The model was trained and internally validated on an 80:20 training/test split of the…
Continue Reading
Croydon Sexual Health and HIV clinic at Croydon Health Services NHS Trust (CSH) has gone live with Inform Health’s electronic patient record (EPR) and personal health record (PHR) systems.
CSH announced plans in February 2025…
Carla Nelson, Sr. Director of Healthcare and Public Policy at Findhelp
The Senate Finance Committee released its version of President Trump’s “Big Beautiful Bill,” but social safety net providers and managed care organizations (MCOs) are…
Continue Reading
Zack Martin, Sr. Policy Advisor at Venable LLP
Hospitals and healthcare systems are facing a growing cyber threat, one that’s being greatly accelerated by generative AI. While much of the public conversation around AI has…
Continue Reading
Background: Smartphone and tablet-based applications have been increasingly utilized in the management of acute STEMI, with the goal of enhancing care efficiency. These applications facilitate improved team coordination through a single platform, enabling secure…
Continue Reading
What You Should Know:
– AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh’s lead investigational candidate, bretisilocin, which is in clinical development for the treatment of patients with…
Continue Reading
